Studying skin cancer tumors after surgery
Part of Cancer, Skin clinical trials.
This trial looks at skin cancer tumors removed during surgery to better understand how they grow. It may help you if you are an adult with a common type of skin cancer called squamous cell carcinoma that is not in a sensitive area and is not too large.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a type of skin cancer called primary cutaneous squamous cell carcinoma.
- The cancer is not on your eyelid, vulva, penis, or near the anus.
- The planned surgery will remove a tumor that is 60 mm (about 2.4 inches) or smaller.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how doctors stage (classify the extent of) a type of skin cancer called cutaneous squamous cell carcinoma. You may be helping researchers by allowing your clinical data to be used for research.
This trial studies a blood test (ctDNA) in people with a type of skin cancer called cutaneous squamous cell carcinoma. It aims to see if the test can help track the cancer and guide treatment decisions.
This study looks at images of a type of skin cancer called squamous cell carcinoma to see if certain features in the images can help predict how deep the cancer has grown. This might help doctors plan treatment without needing extra tests.
This trial tests a device placed on skin cancer lesions to see which drugs might work best. It is for people with visible squamous cell carcinoma on the skin, including lesions that have come back after radiation.
This trial uses a special microscope to look at skin biopsy samples in new ways. It may help doctors understand skin conditions better without needing extra procedures.
This study asks people who had skin cancer surgery about how they feel about their appearance, their scar healing, and their quality of life. It may help doctors understand what outcomes matter most to patients after skin cancer treatment.
Hear when a new Cutaneous Squamous Cell Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.